Literature DB >> 15602647

Results of treatment of distal rectal carcinoma since the introduction of total mesorectal excision: a single unit experience, 1994-2003.

Antonio Chiappa1, Roberto Biffi, Andrew P Zbar, Fabrizio Luca, Cristiano Crotti, Emilio Bertani, Francesca Biella, Giulia Zampino, Roberto Orecchia, Nicola Fazio, Marco Venturino, Cristiano Crosta, Gian Carlo Pruneri, Carmine Grassi, Bruno Andreoni.   

Abstract

BACKGROUND AND AIMS: This study reviewed the results of surgery for distal rectal cancer (where the tumour was within 6 cm of the anal verge) following the introduction of total mesorectal excision for rectal cancer in one institution. PATIENTS AND METHODS: One hundred and fifty-three patients who had undergone elective curative surgical resection of rectal cancer within 6 cm of the anal verge were included. The demographic, operative and follow-up data were collected retrospectively. Comparisons were made between patients who had different surgical procedures.
RESULTS: The overall operative mortality rate was nil, and the morbidity 41%. With a mean follow-up of 37 months (range 5-100 months), local recurrence occurred in 18 of the patients. The 5-year actuarial local recurrence rates for double-stapled anastomosis, low-strength anastomosis and abdominoperineal resection (APR) were 39, 17 and 11% respectively. The local recurrence rate was significantly higher for double-stapled low anterior resection than for the other types of operation (P=0.007). On multivariate analysis type of surgery (P=0.025) and tumour stage (P=0.043), were associated with local recurrence, but only stage was a significant prognosticator of overall survival (P=0.0006).
CONCLUSION: With the practice of total mesorectal excision, APR was still necessary in 40% of patients with rectal cancer within 6 cm of the anal verge. The local recurrence rate was lower in patients treated with APR than in those with double-stapled low anterior resection; however, survival rates were similar in these two groups.

Entities:  

Mesh:

Year:  2004        PMID: 15602647     DOI: 10.1007/s00384-004-0670-9

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  44 in total

1.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

Authors:  E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

2.  Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands.

Authors:  E Kapiteijn; H Putter; C J H van de Velde
Journal:  Br J Surg       Date:  2002-09       Impact factor: 6.939

3.  Local recurrence following total mesorectal excision for rectal cancer.

Authors:  G Arbman; E Nilsson; O Hallböök; R Sjödahl
Journal:  Br J Surg       Date:  1996-03       Impact factor: 6.939

4.  Abdominoperineal excision of the rectum--an endangered operation. Norman Nigro Lectureship.

Authors:  R J Heald; R K Smedh; A Kald; R Sexton; B J Moran
Journal:  Dis Colon Rectum       Date:  1997-07       Impact factor: 4.585

5.  Abdominoperineal resection for locally recurrent rectal cancer.

Authors:  R Bergamaschi; P Pessaux; P Burtin; J P Arnaud
Journal:  Tech Coloproctol       Date:  2001-08       Impact factor: 3.781

6.  Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997.

Authors:  R J Heald; B J Moran; R D Ryall; R Sexton; J K MacFarlane
Journal:  Arch Surg       Date:  1998-08

7.  Total mesorectal excision and local recurrence: a study of tumour spread in the mesorectum distal to rectal cancer.

Authors:  N Scott; P Jackson; T al-Jaberi; M F Dixon; P Quirke; P J Finan
Journal:  Br J Surg       Date:  1995-08       Impact factor: 6.939

8.  Local recurrence following total mesorectal excision with double-stapling anastomosis for rectal cancers: analysis of risk factors.

Authors:  Wai Lun Law; Kin Wah Chu
Journal:  World J Surg       Date:  2002-09-04       Impact factor: 3.352

9.  A prospective study of local recurrence after resection and low stapled anastomosis in 183 patients with rectal cancer.

Authors:  M Rubbini; G F Vettorello; C Guerrera; C Mari; D De Anna; F Mascoli; E Pozza; V Gasbarro; I Donini
Journal:  Dis Colon Rectum       Date:  1990-02       Impact factor: 4.585

10.  Local recurrence after potentially curative resection for rectal cancer in a series of 1008 patients.

Authors:  F T McDermott; E S Hughes; E Pihl; W R Johnson; A B Price
Journal:  Br J Surg       Date:  1985-01       Impact factor: 6.939

View more
  6 in total

1.  Increased use of multidisciplinary treatment modalities adds little to the outcome of rectal cancer treated by optimal total mesorectal excision.

Authors:  Kah Hoong Chang; Myles J Smith; Oliver J McAnena; Arifin S Aprjanto; Joe F Dowdall
Journal:  Int J Colorectal Dis       Date:  2012-03-08       Impact factor: 2.571

2.  Oncological outcomes of transanal local excision for high risk T(1) rectal cancers.

Authors:  Ze-Yu Wu; Gang Zhao; Zhe Chen; Jia-Lin Du; Jin Wan; Feng Lin; Lin Peng
Journal:  World J Gastrointest Oncol       Date:  2012-04-15

3.  Sphincter-preserving operations following preoperative chemoradiation: an alternative to abdominoperineal resection for lower rectal cancer?

Authors:  Jung Wook Huh; Eun Joo Jung; Yoon Ah Park; Kang Young Lee; Seung-Kook Sohn
Journal:  World J Surg       Date:  2008-06       Impact factor: 3.352

4.  Immunoscintigraphy of local recurrent rectal cancer with 99mTc-labeled anti-CEA monoclonal antibody CL58.

Authors:  Yun-Feng Yao; Zhi Yang; Zhen-Fu Li; Jin Gu
Journal:  World J Gastroenterol       Date:  2007-03-28       Impact factor: 5.742

5.  Changes in treatment of rectal cancer: increased use of low anterior resection.

Authors:  A Mekras; A Michalopoulos; V N Papadopoulos; D Mekras; V Kalles; I Tzeveleki; G Dabakis; S Netta; G Basdanis
Journal:  Tech Coloproctol       Date:  2011-10       Impact factor: 3.781

Review 6.  Adjuvant and neoadjuvant chemoradiation or radiotherapy in rectal cancer--a review focusing on open questions.

Authors:  Lutz Moser; Jörg-Peter Ritz; Wolfgang Hinkelbein; Stefan Höcht
Journal:  Int J Colorectal Dis       Date:  2007-12-07       Impact factor: 2.571

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.